SARS-CoV-2: Targeted managements and vaccine development

M Bakhiet, S Taurin - Cytokine & growth factor reviews, 2021 - Elsevier
Infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) results in
diverse outcomes. The symptoms appear to be more severe in males older than 65 and …
被引用次数：100 相关文章

SARS-CoV-2: Targeted managements and vaccine development.

M Bakhiet, S Taurin - Cytokine & Growth Factor Reviews, 2020 - europepmc.org
Infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) results in
diverse outcomes. The symptoms appear to be more severe in males older than 65 and …
[HTML] nih.gov

[HTML][HTML] SARS-CoV-2: Targeted managements and vaccine development

M Bakhiet, S Taurin - Cytokine & Growth Factor Reviews, 2021 - ncbi.nlm.nih.gov
Infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) results in
diverse outcomes. The symptoms appear to be more severe in males older than 65 and …

SARS-CoV-2: Targeted managements and vaccine development

M Bakhiet, S Taurin - Cytokine & growth factor reviews, 2021 - pubmed.ncbi.nlm.nih.gov
Infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) results in
diverse outcomes. The symptoms appear to be more severe in males older than 65 and …